Bioray Biotech Co., Ltd

NT$16.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7561Healthcare
Country Taiwan
PE (Fwd) •••
TSR 6Y CAGR (9.56%)
Div yield 5.94%
ROE 4.40%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM 24.68
TSR TTM (28.19%)
Mkt cap NT$473.4M
ROIC 4.02%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$20
26.39%
(17.03%)
Hold 8|3|8|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.17
0.19
0.21
0.20
23.31%
27.12%
28.53%
28.29%
RevenueNT$M
36.21
37.56
37.31
38.96
4.89%
11.60%
11.26%
11.42%
Peers (US$14.30M)
Cap (US$)
PE
18.13M
1.110x
Capital
TTM
5Y
10Y
Leveragex
0.988
0.988
0.798
EBIT/Intx
0.352
0.272
0.268
Own earn%
(62.91)
(8.26)
(13.62)
Sh yield%
34.21
40.67
41.52
Owners
Insiders/Inst%
14.25
77.98
Short interest%
5.96
SBC / revenue%
2.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
9–17
$1 testx
—
Incr. ROIC%
4